MOG and myeloid sarcoma: The principal limitation is the challenge to extrapolate the findings described in the immune system of aged EAE mice to patients with MS with an age around 50 years old; while the MOG‐induced EAE model provides valuable insights into immune‐mediated mechanisms of MS, it does not fully replicate the complexity of the human disease, including its heterogeneity in clinical progression.